Aspira Women's Health annual meeting results: all proposals approved

Proposal 2: Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 20, 2026, as set forth below: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 5,568,783 505,829 276,305 16,569,699

Proposal 3: Approval of an Amendment to the Aspira Women’s Health Inc. 2019 Stock Incentive Plan The Company’s stockholders approved an amendment to the Company’s 2019 Stock Incentive Plan (the “2019 Plan”) to increase the number of shares of common stock authorized to be granted under the 2019 Plan by 5,000,000 shares so that a total of 9,532,818 shares of common stock are authorized to be granted under the 2019 Plan, as set forth below: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 5,654,497 624,233 72,187 16,569,699

Proposal 4: Ratification of the Selection of the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026, as set forth below: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 22,810,174 15,244 95,198 0